RxSight, Inc. (RXST) compared with its closest peers (STAA, XTNT, QTRX, INFU, STIM). Peer set by Medical Equipment; 10 comparable device makers. First-party data.
STAAR Surgical shares RxSight's sub-industry, ophthalmic goods makers.
| Company | Market Cap | P/E |
|---|---|---|
| STAAR Surgical Company (STAA) | $1.15B | 298.3 |
| Xtant Medical Holdings, Inc. (XTNT) | $58.55M | 26.0 |
| Quanterix Corporation (QTRX) | $123.91M | -2.5 |
| InfuSystem Holdings, Inc. (INFU) | $242.19M | 28.3 |
| Neuronetics, Inc. (STIM) | $192.76M | -2.3 |
| Outset Medical, Inc. (OM) | $69.36M | -0.7 |
| OraSure Technologies, Inc. (OSUR) | $248.98M | -2.6 |
| Pacific Biosciences of California, Inc. (PACB) | $408.74M | -1.0 |
| Anika Therapeutics, Inc. (ANIK) | $288.40M | -12.7 |
| Geospace Technologies Corporation (GEOS) | $66.81M | -24.9 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Medical Equipment) | 29.8 |
RXST overview · RXST earnings · RXST financials · RXST KPIs · RXST documents · RXST ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.